Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
A Multi-center, Dose-escalation Study of Human type I Pancreatic Elastase (PRT-201) Administered after Arteriovenous Fistula Creation
Purpose To explore the safety and efficacy of PRT-201. Methods Randomized, double-blind, placebo-controlled, single-dose escalation study of PRT-201 (0.0033 to 9 mg) applied after arteriovenous… Expand
Application of Human Type I Pancreatic Elastase (PRT-201) to the venous Anastomosis of Arteriovenous Grafts in Patients with Chronic Kidney Disease
- A. Dwivedi, P. Roy‐Chaudhury, +11 authors S. Burke
- Medicine
- The journal of vascular access
- 5 March 2014
Purpose To explore the safety and efficacy of PRT-201 applied to the outflow vein of a newly created arteriovenous graft (AVG). Methods Randomized, double-blind, placebo-controlled, single-dose… Expand
The ability of serum from alpha 1‐antitrypsin–deficient patients to inhibit PRT‐201, a recombinant human type I pancreatic elastase
- A. Qamar, S. Burke, +6 authors F. N. Franano
- Medicine
- Biotechnology and applied biochemistry
- 2012
PRT‐201 is a recombinant human pancreatic elastase under development as a treatment for blood vessels to promote hemodialysis access patency. Proteases such as elastase are normally inactivated by… Expand
Recombinant Human Elastase Alters the Compliance of Atherosclerotic Tibial Arteries After Ex Vivo Angioplasty
- S. Burke, Karen Bingham, +4 authors F. N. Franano
- Medicine
- Journal of cardiovascular pharmacology
- 1 April 2016
Purpose: This study was designed to determine whether vonapanitase (formerly PRT-201), a recombinant human elastase, treatment can fragment the protein elastin in elastic fibers and cause dilation of… Expand
Effects of Recombinant Human Type I Pancreatic Elastase on Human Atherosclerotic Arteries
- S. Burke, Karen Macdonald, +5 authors F. N. Franano
- Medicine
- Journal of cardiovascular pharmacology
- 1 December 2014
Rationale: At physiologic pressures, elastic fibers constrain artery diameter. Local treatment of atherosclerotic arteries with PRT-201, a recombinant type I elastase, could result in fragmentation… Expand
Tumor Transport Physiology: Implications for Imaging and
- B. Kuszyk, F. Corl, +4 authors E. Fishman
- Medicine
- 2001
- 4
Studies of human pancreatic elastase treatment of rabbit and human vein rings to predict human therapeutic doses
- S. Burke, D. Bunton, +5 authors F. N. Franano
- Chemistry, Medicine
- Pharmacology research & perspectives
- 2 April 2016
Vascular tissue contains abundant elastic fibers that contribute to vessel elasticity. Vonapanitase (formerly PRT‐201) is a recombinant human chymotrypsin‐like elastase family member 1 (CELA1) shown… Expand
Recombinant Human Elastase Treatment of Cephalic Veins.
- Marco D. Wong, Karen Bingham, +6 authors S. Burke
- Medicine
- Cardiovascular pharmacology: open access
- 5 April 2016
BACKGROUND
Vessel injury at the time of Arteriovenous Fistula (AVF) creation may lead to neointimal hyperplasia that impairs AVF maturation. Vonapanitase, a recombinant human chymotrypsin-like… Expand
In Vitro Study of a Medical Device to Enhance Arteriovenous Fistula Eligibility and Maturation
- Howard M. Loree, George Agyapong, +4 authors F. N. Franano
- Medicine
- ASAIO journal
- 1 July 2015
The arteriovenous fistula eligibility (AFE) system (Flow Forward Medical, Olathe, KS) is a small, temporary, wearable rotary blood pump system designed to rapidly dilate peripheral veins in… Expand
Data-Based Modelling of the Arteriovenous Fistula Eligibility (AFE) System for Wall Shear Stress Estimation
- Farya Golesorkhie, Zachary Barnes, +4 authors G. Tansley
- Computer Science, Medicine
- Australian & New Zealand Control Conference…
- 1 November 2019
TLDR